At APLUSA, we know that in the pharmaceutical industry, every number matters. Whether you are evaluating physician perceptions, determine sample size, or measuring treatment adoption, statistical rigor is essential. That is why we are proud to announce that the APLUSA Stats app is back online, redesigned to provide fast, reliable, and meaningful calculations directly from your mobile device.
Obesity has become a major public health issue in France. It currently affects more than 8 million...
HER2+ Metastatic Breast Cancer
Breast cancer is a critical health issue affecting millions of women worldwide. October is Breast...
AplusA News, hemato-oncology, ASH, congress
Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...
hemato-oncology, ASH, congress, MDS
Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN with Dr. BLIN, provides...
AplusA News, hemato-oncology, Syndicated Studies, ASH, hematology, congress
Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...
AplusA News, hemato-oncology, ASH, hematology, congress
Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, providing comprehensive...
Notre étude APLUSA révèle l’impact qu’aurait une recommandation des autorités en faveur d’un vaccin...
AplusA ensures you are up-to-date with the latest vaccine market developments.
Over 30 years,...
The goal of this newsletter is to give an overview of what is happening around multiple myeloma in ...